Company profile

ONCY stock data

(
)

Calendar

15 Mar 19
18 Jan 20
31 Dec 20

News

Company financial data Financial data

13F holders
Current Prev Q Change
Total holders 24 21 +14.3%
Opened positions 5 3 +66.7%
Closed positions 2 4 -50.0%
Increased positions 4 4
Reduced positions 2 4 -50.0%
13F shares
Current Prev Q Change
Total value 226K 987K -77.1%
Total shares 398.58K 579.59K -31.2%
Total puts 0 0 NaN%
Total calls 0 0 NaN%
Total put/call ratio NaN NaN NaN%
Largest owners
Shares Value Change
MS Morgan Stanley 203.01K $115K +259.6%
Scotia Capital 48.04K $28K 0.0%
Renaissance Technologies 37.75K $22K NEW
Magnus Financial 25K $14K +150.0%
Citadel Advisors 16.92K $10K NEW
Comerica Bank 15.53K $8K 0.0%
DB Deutsche Bank 13.28K $7K +188.6%
RY Royal Bank of Canada 11.56K $7K +2.2%
Patriot Financial Group Insurance Agency 10.7K $6K -7.8%
BMO Bank Of Montreal 6.07K $4K -7.8%
Largest transactions
Shares Bought/sold Change
Verition Fund Management 0 -408.84K EXIT
MS Morgan Stanley 203.01K +146.55K +259.6%
Renaissance Technologies 37.75K +37.75K NEW
Citadel Advisors 16.92K +16.92K NEW
Magnus Financial 25K +15K +150.0%
DB Deutsche Bank 13.28K +8.68K +188.6%
TD Toronto Dominion Bank 4.5K +4.5K NEW
Patriot Financial Group Insurance Agency 10.7K -900 -7.8%
BMO Bank Of Montreal 6.07K -514 -7.8%
Captrust Financial Advisors 0 -440 EXIT

Financial report summary

?
Competition
AdvaxisBioLineRx
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: AACR, absolute, adding, aid, Albert, Allison, Altana, Altimmune, amortised, APEGA, Appendix, ASCO, atezolizumab, Atkin, banker, Basel, bio, BioInvent, Biome, biosimilar, blackout, Buckland, cancellation, Cardiol, cessation, chapter, charity, Chemical, colon, Comimittee, Commerce, criterion, CryptoMedix, device, disability, Dover, ECL, England, Equicom, escape, ESMO, exploring, fallen, family, feature, FleishmanHillard, forfeited, fraction, Fractional, Freiburg, FVOCI, FVPL, gastroenterological, Genentech, Germany, GI, Hagerman, HBSPCA, Hepatology, housekeeping, immunomodulatory, IMV, inconsistent, inter, Jan, Jersey, Laeufle, Lancet, Leader, led, lieu, London, Ludwig, lymphocyte, Maryland, Master, matrix, MBT, Michael, Moore, Mount, nearest, NIRI, numerator, ONCYD, PARP, Pathology, PD, peripheral, Pharmacovigilance, PMI, PMP, prejudice, priming, PRK, Provention, Province, PSA, qualitative, quickly, Rat, reclassification, redeemed, redesignation, redivision, reissuing, reorganization, rest, Restated, Rita, rounded, ROW, RRSP, RSA, rtained, Rucaparib, sarcoma, Scotiabank, SFJ, shortfall, simplified, Singen, SPPI, Sr, subdivision, surgery, Switzerland, takeover, Tecentriq, thyroid, Trademark, treasurer, Ueberlingen, unexercised, unvested, upregulate, valuable, vasculature, voluntarily, WCGC
Removed: accredited, accretion, buy, buying, Certification, choosing, CSA, delivery, discourage, distinction, enable, ethical, explaining, explanatory, guaranteed, hand, harder, impaired, insignificant, invested, lessor, liquid, match, measure, offer, Opsona, OTC, penny, problem, reached, readily, recommending, reliably, REOLYSIN, replace, selling, suitability, unchanged, venture, venturing, version, wholly

Proxies

No filings